Redefine Patient Care
Is your practice leading the way with innovative treatment options?
Tackle Pain and Aesthetic Concerns FAST
Learn about non-surgical, low-risk treatment options that allow you to stay active.
Cutting-Edge Solutions
Set your practice apart by offering the regenerative solutions your patients are seeking.
The new Radial Pressure Wave (RPW) system, the OrthoPulse One available from CuraMedix, also known as MASTERPULSE One®, was developed by STORZ Medical with a clear focus on maximum ease of use, compact design, high efficiency, and perfect mobility.
The accompanying SPARROW® radial handpiece represents minimalist design at its best. Excellent damping during pressure wave generation reduces handpiece vibrations.
The OrthoPulse One is ideal for medical professionals looking for an RPW device to take on the road or to the field to supplement their in-office EPAT/ESWT treatments.
The OrthoPulse One EPAT® system includes:
With its progressive technological advancements, Extracorporeal Pulse Activation Technology (EPAT), often referred to as ESWT or shockwave therapy, delivers an evidence-based*, non-surgical solution for patients suffering from chronic heel pain.
It addresses the increasing demand for patient convenience, less down-time and risk, as well as better clinical and economic outcomes, and improved practice efficiencies and cash-flow.
Health care professionals are using shockwave to successfully treat acute or chronic musculoskeletal pain and/or pain that significantly impairs mobility or quality of life.
Areas include:
Better quality of care. Higher satisfaction rates. Practice differentiation. Increased revenue. Hear about the experiences from physicians who have successfully integrated EPAT® and other leading regenerative solutions into their continuum of care.
The best way to advance patient care for your practice is looking to the evidence that’s available for new technologies and protocols. CuraMedix solutions like EPAT® are backed by clinical studies and are evidence-based; whereas similar competing technologies cannot make this claim.